$OLN

OLIN Corp (OLN): Results of Operations and Financial Condition

OLIN Corp (OLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Investor Contact: Steve Keenan (314) 719-1755 InvestorRelations@Olin.com News Olin Corporation, 190 Carondelet Plaza, Suite 1530, Clayton, MO 63105 Olin Announces Second Quarter 2026 Results Highlights • Second quarter 2026 net loss of ($13.3) million, or ($0.12) per

Original reporting
Published Jul 30, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$OLN
Bearish
medium confidence
Mentioned
$OLN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OLNBearishHigh
01

Why it matters

Traders should focus on the quantified Freeport shutdown impact, the expected $20M third-quarter disruption effect, and the provided Q3 adjusted EBITDA range ($160M-$200M). The filing also reiterates merger timing (expected first half 2027) and notes acquisition-related costs included in Q2 results.

02

Market read

The combination of a plant outage with explicit EBITDA impact and a concrete Q3 EBITDA range makes this a direct catalyst for earnings expectations and positioning.

03

What to watch

The Blue Water Alliance JV ended operations at end-2025, and legacy Shintech litigation payments affect working capital and cash flow optics, which can matter for near-term credit and equity sentiment.

Relevance 7/10Novelty 9/10Timing: after-hours filing of Q2 2026 results and Q3 adjusted EBITDA outlook
alphai · Earnings readOLN · second quarter 2026 · ended June 30, 2026

Olin Announces Second Quarter 2026 Results

Mixed quarter

Second quarter sales were lower than the second quarter 2025 comparison and Olin reported a larger net loss, while adjusted EBITDA increased and Epoxy and Winchester segment earnings improved. The company forecast third quarter adjusted EBITDA of $160 million to $200 million, with Chemical results expected to be comparable to the second quarter and Winchester expected to deliver sequential earnings growth.

Chlor Alkali Products and Vinyls
$819.5 million
EPS · GAAP
($0.12)

Key metrics

as reported
MetricValueq/qy/y
SalesGAAP$1,741.9 million
Net lossGAAP($13.3) million
Net loss per diluted shareGAAP($0.12) per diluted share
Adjusted EBITDAnon-GAAP$191.3 million
Depreciation and amortization expenseother$122.1 million
Acquisition-related costsother$10.6 million
Restructuring chargesother$10.5 million
Chlor Alkali Products and Vinyls segment earningsother$53.4 million
Chlor Alkali Products and Vinyls depreciation and amortization expenseother$98.1 million
Chlor Alkali Products and Vinyls operating-issue impactother$40.1 million
Epoxy segment earningsother$16.0 million
Epoxy depreciation and amortization expenseother$11.7 million
Winchester segment earningsother$28.1 million
Winchester depreciation and amortization expenseother$8.8 million
Other corporate and unallocated costs increaseother$5.4 million

Segments

SegmentRevenueq/qy/y
Chlor Alkali Products and VinylsSales decreased due to lower volumes, primarily from lower trading volumes associated with Blue Water Alliance and lower vinyl chloride monomer volumes. The Blue Water Alliance joint venture concluded operations at the end of 2025. Segment results were negatively impacted by operating issues at the Freeport, Texas vinyl chloride monomer plant, while the remaining increase in segment earnings was primarily due to higher caustic soda and ethylene dichloride pricing, partially offset by higher natural gas and electrical power costs.$819.5 million
EpoxySales increased due to higher volumes and improved pricing. Segment earnings increased primarily because of higher volumes, improved product margins, and lower operating costs; higher pricing was partially offset by higher benzene and propylene costs.$422.1 million
WinchesterSales increased primarily due to higher commercial ammunition sales and higher military project revenue. Segment earnings increased primarily due to higher commercial ammunition pricing and volume and higher military project revenue, partially offset by higher commodity metal costs and higher operating costs.$500.3 million

third quarter 2026 outlook

  • NoteAdjusted EBITDA is forecast to be in the range of $160 million to $200 million.
  • NoteChemical businesses' third quarter 2026 results are expected to be comparable to the second quarter.
  • NoteReduced operating rates at the vinyl chloride monomer facility and weaker ethylene dichloride pricing are expected to offset stronger caustic soda volumes.
  • NoteSeasonally improving commercial demand is expected to support sequential earnings growth in Winchester.
  • NoteThe vinyl chloride monomer disruption is estimated to have a $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter.

What drove it

  • Chlor Alkali Products and Vinyls benefited from improved caustic soda and ethylene dichloride pricing and favorable operating performance driven by Beyond250 structural cost actions.
  • Epoxy margins expanded despite persistent weak demand conditions in Europe.
  • Winchester's sequential improvement was driven by stronger commercial demand and pricing actions implemented to offset commodity metals and raw materials cost inflation.
  • Epoxy sales benefited from higher volumes and improved pricing.
  • Winchester sales benefited from higher commercial ammunition sales and higher military project revenue.

Concerns

  • The unplanned shutdown of the Freeport, Texas vinyl chloride monomer plant reduced second quarter adjusted EBITDA by $40 million; operations resumed at reduced rates.
  • Sales in Chlor Alkali Products and Vinyls declined due to lower volumes, including lower trading volumes associated with Blue Water Alliance and lower vinyl chloride monomer volumes.
  • The company cited persistent weak demand conditions in Europe for Epoxy.
  • Higher raw material costs, including natural gas, electrical power, benzene, propylene, and commodity metals, partially offset segment benefits.
  • Other corporate and unallocated costs increased $5.4 million primarily due to an unfavorable impact from foreign currency.
  • Net debt was approximately $2.85 billion and the net debt to adjusted EBITDA ratio was 5.0 times.

What to watch

  • The timing of full-rate resumption at the Freeport vinyl chloride monomer facility, planned for late in the third quarter.
  • The estimated $20 million third-quarter impact from the vinyl chloride monomer disruption.
  • Whether stronger caustic soda volumes offset weaker ethylene dichloride pricing and reduced vinyl chloride monomer operating rates.
  • Seasonally improving commercial demand and sequential earnings growth at Winchester.
  • The expected liquidation of normal seasonal first-half working capital during the second half.
  • The remaining approximately $100 million legacy Shintech litigation payment expected in the second half of 2026.
  • Progress toward the expected first-half 2027 completion of the all-stock merger of equals with Huntsman Corporation, subject to closing conditions and approvals.

Balance sheet and cash flow

  • Cash balance on June 30, 2026: $177.4 million.
  • Net debt at the end of the second quarter 2026: approximately $2.85 billion.
  • Net debt to adjusted EBITDA ratio: 5.0 times.
  • Available liquidity on June 30, 2026: approximately $1.2 billion, including unrestricted access to the undrawn portion of its revolving credit facility.
  • Working capital increased $183.0 million in the first half 2026.
  • Olin paid approximately $93 million, including previously accrued reserves, to resolve legacy Shintech litigation matters and expects to pay the remaining approximately $100 million in the second half of 2026.

Analysis

Olin reported second quarter sales of $1,741.9 million, compared with $1,758.3 million in the second quarter 2025. The company posted a reported net loss of ($13.3) million, or ($0.12) per diluted share, compared with a reported net loss of ($1.3) million, or ($0.01) per diluted share. Adjusted EBITDA was $191.3 million, compared with $176.1 million in the second quarter 2025; the reported adjusted figure excluded $122.1 million of depreciation and amortization expense, $10.6 million of acquisition-related costs, and $10.5 million of restructuring charges.

Chlor Alkali Products and Vinyls was the principal sales headwind. Segment sales were $819.5 million compared with $979.5 million, with lower trading volumes associated with Blue Water Alliance and lower vinyl chloride monomer volumes cited as causes. Segment earnings were $53.4 million compared with $64.9 million. Operating issues at the Freeport vinyl chloride monomer plant had a $40.1 million negative impact on segment results through higher costs and lost-sales profit, while higher caustic soda and ethylene dichloride pricing supported the remaining segment earnings improvement described by the company.

Epoxy and Winchester supplied the positive segment developments. Epoxy sales were $422.1 million compared with $331.2 million, and segment earnings were $16.0 million compared with a segment loss of ($23.7) million. Higher volumes, improved product margins, and lower operating costs drove the Epoxy result, although the release identified persistent weak demand conditions in Europe and higher benzene and propylene costs. Winchester sales were $500.3 million compared with $447.6 million, while segment earnings were $28.1 million compared with $25.0 million, supported by commercial ammunition pricing and volume as well as military project revenue.

Liquidity metrics show $177.4 million of cash, approximately $2.85 billion of net debt, and a 5.0 times net debt to adjusted EBITDA ratio at June 30, 2026. Available liquidity was approximately $1.2 billion. Working capital increased $183.0 million in the first half 2026. Olin also paid approximately $93 million to resolve legacy Shintech litigation matters and expects the remaining approximately $100 million payment in the second half of 2026.

For the third quarter, Olin forecast adjusted EBITDA of $160 million to $200 million. Management expects Chemical business results to be comparable to the second quarter because reduced vinyl chloride monomer operating rates and weaker ethylene dichloride pricing offset stronger caustic soda volumes. The plant disruption is expected to have a $20 million third-quarter impact, with full rates planned to resume late in the quarter. The pending all-stock merger of equals with Huntsman generated $10.6 million of second-quarter acquisition-related costs and is expected to occur in the first half of 2027, subject to customary conditions and required approvals.

Management, verbatim

The Olin team delivered sequential improvement in adjusted EBITDA in a highly volatile environment. Our Chlor Alkali Products and Vinyls business benefited from improved caustic soda and ethylene dichloride pricing and from favorable operating performance driven by our Beyond250 structural cost actions. However, partially offsetting this performance was an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas. Operations have resumed at reduced rates. The disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter. Epoxy continued to improve as margins expanded despite persistent weak demand conditions in Europe. Winchester’s sequential improvement was driven by stronger commercial demand and pricing actions implemented to offset commodity metals and raw materials cost inflation.

Ken Lane, President and Chief Executive Officer

Looking ahead, we expect our Chemical businesses’ third quarter 2026 results to be comparable to the second quarter, as reduced operating rates at the vinyl chloride monomer facility and weaker ethylene dichloride pricing offset expected stronger caustic soda volumes. In our Winchester business, seasonally improving commercial demand is expected to support sequential earnings growth. With continued significant global volatility, third quarter 2026 adjusted EBITDA is forecast to be in the range of $160 million to $200 million.

Ken Lane, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Prior-quarter sales, net income or loss, EPS, adjusted EBITDA, segment sales, and segment earnings were not reported.
  • Gross profit, gross margin, operating income, operating margin, interest expense, income-tax expense, tax rate, and non-GAAP EPS were not provided in the filing text.
  • Operating cash flow, capital expenditures, free cash flow, total debt, and debt maturities were not provided in the filing text.
  • Share repurchases, dividends declared or paid, and other capital-return amounts were not reported.
  • No previous outlook section was provided, so no comparison of reported results with prior guidance is available.
  • Numerical third-quarter guidance for revenue, gross margin, operating expenses, and tax rate was not provided.

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC 8-K (Item 2.02) with Olin’s Q2 2026 earnings release (Exhibit 99.1) and includes segment performance, liquidity, and the status of the proposed all-stock merger with Huntsman.

Company-level read

Ticker impact

$OLNBearishMedium confidence
Context

Olin reported Q2 2026 results with a Freeport, Texas vinyl chloride monomer plant shutdown cutting adjusted EBITDA by about $40 million and guiding Q3 EBITDA to $160M-$200M.

Expected impact

Bias toward volatility and downside risk versus expectations until the market prices the $20M estimated Q3 impact and the late-quarter return to full rates.

Evidence & confidence

The filing provides quantified disruption impact ($40M Q2, ~$20M Q3) plus a specific Q3 adjusted EBITDA range, which should drive immediate repricing and positioning.

Market effects

Chlor-alkali and vinyls producers may see read-across on how plant outages and ethylene dichloride pricing affect margins and EBITDA ranges.

Freeport, Texas operational disruption highlights Gulf Coast chemical supply-chain sensitivity.

Europe epoxy demand remains weak, but margins are improving, which may influence regional pricing expectations.

Counterpoint

Despite the Freeport outage, Olin’s adjusted EBITDA remains high ($191.3M) and caustic soda/ethylene dichloride pricing plus Beyond250 cost actions are offsetting part of the disruption.

Key entities

  • OLIN Corp

    Reported Q2 2026 results, disclosed Freeport vinyl chloride monomer plant shutdown impact, and provided Q3 adjusted EBITDA guidance.

  • Huntsman Corporation

    Announced a definitive all-stock merger agreement with Olin; completion expected in first half 2027 subject to approvals.

Every OLN earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$OLNHighAI 9/10

What Does Olin (OLN) Shareholder Approval Mean For Its Merger Deal?

Olin (NYSE: OLN) shareholders approved a merger with Huntsman, a key step for the deal's completion. Both companies' investors backed the transaction, which aims to create a larger global competitor with a broader product portfolio. The merger shifts Olin's focus from cost cuts to integration risks, with the deal expected to close in early 2027. Olin has a market cap of about $2.0 billion and operates globally.

$HUNHighAI 8/10

Huntsman Stockholders Approve Olin Merger Agreement at Special Meeting

Huntsman Corporation (NYSE:HUN) stockholders approved a merger agreement with Olin and an advisory proposal on executive compensation at a special meeting. The board recommended approval, and no adjournment vote was needed due to sufficient support. Final results will be filed with the SEC. Huntsman is a global specialty chemicals manufacturer.

$HUNHighAI 9/10

Huntsman, the polyurethane leader, completes merger with Olin

Huntsman and Olin shareholders approved a merger, creating OlinHuntsman with expected $12.5B revenue and $12B market value. Olin shareholders will hold 54.5% equity, Huntsman 45.5%. The merger aims to leverage industrial synergies, with Olin providing chlorine gas to Huntsman's polyurethane production. Huntsman reported 2025 revenue of $5.683B, a 5.8% decline, and a net loss of $284M. The merger is expected to close in 2027.

$OLNMedAI 9/10

Olin Shareholders Approve Merger of Equals with Huntsman – Minichart

Olin (NYSE: OLN) shareholders approved a merger with Huntsman (NYSE: HUN) with 97% of votes in favor. The deal, expected to close in early 2027, requires regulatory approval. Huntsman shareholders also approved the deal with 99% support. The merger aims to create a global chemicals company, OlinHuntsman, combining both firms' businesses.

$OLNMedAI 9/10

Olin, Huntsman Shareholders Approve $12.5 Billion Chemicals Merger

Olin Corp. (OLN) and Huntsman Corp. (HUN) shareholders approved their $12.5B all-stock merger, with 97% of Olin and 99% of Huntsman votes in favor. The deal, expected to close in 2027, will create OlinHuntsman Corp., with combined revenue of $12.5B and 14,000 employees. The merger aims to generate $400M in annual cost savings and expand market reach.